WO2006053379A1 - Improved nutraceutical composition - Google Patents
Improved nutraceutical composition Download PDFInfo
- Publication number
- WO2006053379A1 WO2006053379A1 PCT/AU2005/001741 AU2005001741W WO2006053379A1 WO 2006053379 A1 WO2006053379 A1 WO 2006053379A1 AU 2005001741 W AU2005001741 W AU 2005001741W WO 2006053379 A1 WO2006053379 A1 WO 2006053379A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- phytonutrient
- nutritional
- composition according
- nutraceutical
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 169
- 239000002417 nutraceutical Substances 0.000 title claims abstract description 85
- 235000021436 nutraceutical agent Nutrition 0.000 title claims abstract description 85
- 239000000284 extract Substances 0.000 claims abstract description 44
- 239000000463 material Substances 0.000 claims abstract description 18
- 230000000694 effects Effects 0.000 claims abstract description 14
- 235000013305 food Nutrition 0.000 claims description 93
- 235000016709 nutrition Nutrition 0.000 claims description 70
- 239000000126 substance Substances 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 35
- -1 dichalcones Chemical class 0.000 claims description 33
- 235000021281 monounsaturated fatty acids Nutrition 0.000 claims description 33
- 241000196324 Embryophyta Species 0.000 claims description 32
- 239000002537 cosmetic Substances 0.000 claims description 31
- 235000021466 carotenoid Nutrition 0.000 claims description 25
- 235000013311 vegetables Nutrition 0.000 claims description 23
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 claims description 20
- 235000011957 flavonols Nutrition 0.000 claims description 20
- 235000012041 food component Nutrition 0.000 claims description 20
- 241000234282 Allium Species 0.000 claims description 19
- 241000220225 Malus Species 0.000 claims description 17
- 235000011430 Malus pumila Nutrition 0.000 claims description 17
- 235000015103 Malus silvestris Nutrition 0.000 claims description 17
- 235000013734 beta-carotene Nutrition 0.000 claims description 17
- 239000011648 beta-carotene Substances 0.000 claims description 17
- 229930003944 flavone Natural products 0.000 claims description 15
- 235000011949 flavones Nutrition 0.000 claims description 15
- 201000010099 disease Diseases 0.000 claims description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 13
- 150000002216 flavonol derivatives Chemical class 0.000 claims description 12
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 11
- 239000008157 edible vegetable oil Substances 0.000 claims description 11
- 150000002213 flavones Chemical class 0.000 claims description 11
- 206010028980 Neoplasm Diseases 0.000 claims description 10
- 201000011510 cancer Diseases 0.000 claims description 10
- 241001677259 Acanthophoenix rubra Species 0.000 claims description 9
- 240000002234 Allium sativum Species 0.000 claims description 9
- 235000019482 Palm oil Nutrition 0.000 claims description 9
- 229930014669 anthocyanidin Natural products 0.000 claims description 9
- 235000008758 anthocyanidins Nutrition 0.000 claims description 9
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 claims description 9
- 235000004611 garlic Nutrition 0.000 claims description 9
- 125000004383 glucosinolate group Chemical group 0.000 claims description 9
- 239000004006 olive oil Substances 0.000 claims description 9
- 235000008390 olive oil Nutrition 0.000 claims description 9
- 239000002540 palm oil Substances 0.000 claims description 9
- 235000005254 Allium ampeloprasum Nutrition 0.000 claims description 8
- 240000006108 Allium ampeloprasum Species 0.000 claims description 8
- 239000004215 Carbon black (E152) Substances 0.000 claims description 8
- 150000001720 carbohydrates Chemical class 0.000 claims description 8
- 230000002596 correlated effect Effects 0.000 claims description 8
- 229930003949 flavanone Natural products 0.000 claims description 8
- 235000011981 flavanones Nutrition 0.000 claims description 8
- 150000002208 flavanones Chemical class 0.000 claims description 8
- 235000021384 green leafy vegetables Nutrition 0.000 claims description 8
- 229930195733 hydrocarbon Natural products 0.000 claims description 8
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 8
- 150000002515 isoflavone derivatives Chemical class 0.000 claims description 8
- 235000008696 isoflavones Nutrition 0.000 claims description 8
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 claims description 7
- 235000014443 Pyrus communis Nutrition 0.000 claims description 7
- 150000001748 carotenols Chemical class 0.000 claims description 7
- 235000005471 carotenols Nutrition 0.000 claims description 7
- 235000005513 chalcones Nutrition 0.000 claims description 7
- 150000001789 chalcones Chemical class 0.000 claims description 7
- 235000011869 dried fruits Nutrition 0.000 claims description 7
- DEDGUGJNLNLJSR-UHFFFAOYSA-N enol-phenylpyruvic acid Chemical class OC(=O)C(O)=CC1=CC=CC=C1 DEDGUGJNLNLJSR-UHFFFAOYSA-N 0.000 claims description 7
- 229930003658 monoterpene Natural products 0.000 claims description 7
- 150000002773 monoterpene derivatives Chemical class 0.000 claims description 7
- 235000002577 monoterpenes Nutrition 0.000 claims description 7
- 229940112042 peripherally acting choline derivative muscle relaxants Drugs 0.000 claims description 7
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 7
- 150000007965 phenolic acids Chemical class 0.000 claims description 7
- 235000009048 phenolic acids Nutrition 0.000 claims description 7
- 229940068065 phytosterols Drugs 0.000 claims description 7
- 150000003248 quinolines Chemical class 0.000 claims description 7
- 150000001629 stilbenes Chemical class 0.000 claims description 7
- 235000021286 stilbenes Nutrition 0.000 claims description 7
- 230000032683 aging Effects 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 150000002898 organic sulfur compounds Chemical class 0.000 claims description 6
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 5
- 239000013543 active substance Substances 0.000 claims description 5
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 235000006708 antioxidants Nutrition 0.000 claims description 5
- 230000003412 degenerative effect Effects 0.000 claims description 5
- 235000015872 dietary supplement Nutrition 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 239000005556 hormone Substances 0.000 claims description 5
- 229940088597 hormone Drugs 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- 239000000654 additive Substances 0.000 claims description 4
- 230000000996 additive effect Effects 0.000 claims description 4
- 230000000844 anti-bacterial effect Effects 0.000 claims description 4
- 235000014633 carbohydrates Nutrition 0.000 claims description 4
- 239000000490 cosmetic additive Substances 0.000 claims description 4
- 230000006866 deterioration Effects 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 4
- 239000003925 fat Substances 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 230000036559 skin health Effects 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 206010027654 Allergic conditions Diseases 0.000 claims description 3
- 208000024827 Alzheimer disease Diseases 0.000 claims description 3
- 208000023275 Autoimmune disease Diseases 0.000 claims description 3
- 208000020084 Bone disease Diseases 0.000 claims description 3
- 208000012659 Joint disease Diseases 0.000 claims description 3
- 208000027771 Obstructive airways disease Diseases 0.000 claims description 3
- 208000001132 Osteoporosis Diseases 0.000 claims description 3
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 3
- 206010003246 arthritis Diseases 0.000 claims description 3
- 208000006673 asthma Diseases 0.000 claims description 3
- 239000011230 binding agent Substances 0.000 claims description 3
- 210000000988 bone and bone Anatomy 0.000 claims description 3
- 230000001276 controlling effect Effects 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 3
- 239000003205 fragrance Substances 0.000 claims description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 3
- 229940088710 antibiotic agent Drugs 0.000 claims description 2
- 239000007844 bleaching agent Substances 0.000 claims description 2
- 239000000872 buffer Substances 0.000 claims description 2
- 239000004067 bulking agent Substances 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims description 2
- 239000007854 depigmenting agent Substances 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims description 2
- 239000003349 gelling agent Substances 0.000 claims description 2
- 230000000887 hydrating effect Effects 0.000 claims description 2
- 239000000314 lubricant Substances 0.000 claims description 2
- 239000004014 plasticizer Substances 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 240000001987 Pyrus communis Species 0.000 claims 3
- 229930003935 flavonoid Natural products 0.000 description 20
- 150000002215 flavonoids Chemical class 0.000 description 20
- 235000017173 flavonoids Nutrition 0.000 description 20
- 210000003491 skin Anatomy 0.000 description 15
- 239000000047 product Substances 0.000 description 12
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 11
- 150000001747 carotenoids Chemical class 0.000 description 11
- 235000011987 flavanols Nutrition 0.000 description 11
- 235000013399 edible fruits Nutrition 0.000 description 10
- 240000008415 Lactuca sativa Species 0.000 description 9
- 150000002206 flavan-3-ols Chemical class 0.000 description 9
- 150000007946 flavonol Chemical class 0.000 description 8
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 8
- 235000012045 salad Nutrition 0.000 description 8
- 235000013365 dairy product Nutrition 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 235000010469 Glycine max Nutrition 0.000 description 6
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 6
- 244000269722 Thea sinensis Species 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 238000006722 reduction reaction Methods 0.000 description 6
- 235000014347 soups Nutrition 0.000 description 6
- 230000000699 topical effect Effects 0.000 description 6
- 241000220324 Pyrus Species 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 235000013616 tea Nutrition 0.000 description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 4
- 239000005864 Sulphur Substances 0.000 description 4
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000003217 anti-cancerogenic effect Effects 0.000 description 4
- 230000002790 anti-mutagenic effect Effects 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 230000003292 diminished effect Effects 0.000 description 4
- 150000002212 flavone derivatives Chemical class 0.000 description 4
- 239000005417 food ingredient Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000007407 health benefit Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 150000003505 terpenes Chemical class 0.000 description 4
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 4
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 3
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- YTAQZPGBTPDBPW-UHFFFAOYSA-N flavonoid group Chemical group O1C(C(C(=O)C2=CC=CC=C12)=O)C1=CC=CC=C1 YTAQZPGBTPDBPW-UHFFFAOYSA-N 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 230000008821 health effect Effects 0.000 description 3
- 235000008777 kaempferol Nutrition 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 3
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 3
- 229940116852 myricetin Drugs 0.000 description 3
- 235000007743 myricetin Nutrition 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 235000005875 quercetin Nutrition 0.000 description 3
- 229960001285 quercetin Drugs 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 230000037380 skin damage Effects 0.000 description 3
- 235000011888 snacks Nutrition 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 3
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 2
- 231100000716 Acceptable daily intake Toxicity 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241001133760 Acoelorraphe Species 0.000 description 2
- 241000219198 Brassica Species 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- OEIJRRGCTVHYTH-UHFFFAOYSA-N Favan-3-ol Chemical compound OC1CC2=CC=CC=C2OC1C1=CC=CC=C1 OEIJRRGCTVHYTH-UHFFFAOYSA-N 0.000 description 2
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 2
- 239000001828 Gelatine Substances 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 2
- ZFAHNWWNDFHPOH-YFKPBYRVSA-N S-allylcysteine Chemical compound OC(=O)[C@@H](N)CSCC=C ZFAHNWWNDFHPOH-YFKPBYRVSA-N 0.000 description 2
- IDIDJDIHTAOVLG-VKHMYHEASA-N S-methylcysteine Chemical compound CSC[C@H](N)C(O)=O IDIDJDIHTAOVLG-VKHMYHEASA-N 0.000 description 2
- 206010040954 Skin wrinkling Diseases 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 239000007894 caplet Substances 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- 150000001765 catechin Chemical class 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 description 2
- 229920002770 condensed tannin Polymers 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 229940030275 epigallocatechin gallate Drugs 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000012055 fruits and vegetables Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 235000012680 lutein Nutrition 0.000 description 2
- 239000001656 lutein Substances 0.000 description 2
- 229960005375 lutein Drugs 0.000 description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 2
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 2
- 235000009498 luteolin Nutrition 0.000 description 2
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 2
- 239000001751 lycopene Substances 0.000 description 2
- 235000012661 lycopene Nutrition 0.000 description 2
- 229960004999 lycopene Drugs 0.000 description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- 239000002966 varnish Substances 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 241001280436 Allium schoenoprasum Species 0.000 description 1
- 235000001270 Allium sibiricum Nutrition 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 241000219122 Cucurbita Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 108091006149 Electron carriers Proteins 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 description 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 244000081841 Malus domestica Species 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 235000002725 Olea europaea Nutrition 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- ZFAHNWWNDFHPOH-UHFFFAOYSA-N S-Allyl-L-cystein Natural products OC(=O)C(N)CSCC=C ZFAHNWWNDFHPOH-UHFFFAOYSA-N 0.000 description 1
- IDIDJDIHTAOVLG-UHFFFAOYSA-N S-methyl-L-cysteine Natural products CSCC(N)C(O)=O IDIDJDIHTAOVLG-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 241000482268 Zea mays subsp. mays Species 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 244000193174 agave Species 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 239000000420 anogeissus latifolia wall. gum Substances 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000842 anti-protozoal effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 125000001895 carotenoid group Chemical group 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000027721 electron transport chain Effects 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000019261 food antioxidant Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- 230000000273 goitrogenic effect Effects 0.000 description 1
- 235000014168 granola/muesli bars Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000019314 gum ghatti Nutrition 0.000 description 1
- 201000010235 heart cancer Diseases 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000024348 heart neoplasm Diseases 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000008311 hydrophilic ointment Substances 0.000 description 1
- KOTBWDXNYNTNIY-YHEDCBSUSA-N hydroxycarotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C KOTBWDXNYNTNIY-YHEDCBSUSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002766 immunoenhancing effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 150000002628 limonene derivativess Chemical class 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 235000011475 lollipops Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 239000008164 mustard oil Substances 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 235000014594 pastries Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
- 235000013573 potato product Nutrition 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 235000021455 prepackaged meals Nutrition 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 235000003687 soy isoflavones Nutrition 0.000 description 1
- 235000020354 squash Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 108010058651 thioglucosidase Proteins 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 150000003669 ubiquinones Chemical class 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Definitions
- the present invention relates to a nutraceutical and/or cosmetic composition and/or modified food composition derived from one or more extracts of various plant components.
- the present invention also relates to a method of prophylactically or therapeutically treating a disease or degenerative effect
- phytonutrients As well as contributing to the colour, texture, flavour and smell of plants and plant derived foods, phytonutrients have complementary and overlapping biological effects, including antioxidant effects, modulation of detoxification enzymes, stimulation of the immune system, modulation of hormone metabolism and antibacterial and antiviral effects.
- Phytonutrients can be categorised in accordance with either their plant sources, chemical structure or functions.
- phytonutrients in food products are classified according to their functions, such as antioxidants or phytoestrogens, which reflect phytonutrient content. This classification is less than satisfactory however as the actual health benefits many phytonutrients provide is, as yet, poorly defined.
- discussion of phytonutrients is conducted based on a classification by chemical structure, for example carotenoids, flavonoids and glucosinolates. However, such a classification is not admitted to be commonly used or employed, particularly in the food industry.
- Flavonoids are polyphenols compounds comprising 15 carbon atoms, with two aromatic rings connected by a three carbon bridge. They are found throughout the plant kingdom, present in high concentrations in the epidermis of leaves and the skin of fruit.
- Flavonoids have been found in fruits and vegetables including apples, pears and onions as well as in tea and wine. In plants, flavonoids, as secondary metabolites, are involved in diverse processes, such as UV protection, pigmentation, stimulation of nitrogen-fixing nodules and disease resistance.
- Flavonoids consist mainly of flavonols (kaempferol, quercetin, myricetin), flavones (apigenin, luteolin), flavanols (catechins, epicatechins, proanthocyanins), isoflavones (daidzein, genistein), flavanones (naringin, hesperidin), and anthocyanidins.
- flavonoids By acting as antioxidants, flavonoids reduce oxidative damage to DNA and influence other processes of cell proliferation that are regulated through the oxidation-reduction reactions. In addition, they can modulate the activity of specific phase I and phase Il enzymes and therefore inhibit the metabolic activation of carcinogens.
- Flavonols in particular epigallocatechin gallate (EGCC), have been identified as the principal antimutagenic and anticarcinogenic compound in green tea. The beneficial effects of drinking tea have been observed in relation to blood pressure, serum cholesterol and other lipids.
- EGCC epigallocatechin gallate
- Carotenoids (jS-carotene, lycopene, lutein) are the most well-known of a group known as terpenoids, which are structurally very diverse and are classified according to the number of C5 isoprenoid units incorporated in their structures.
- the pro-vitamin A activity is probably the first function known for dietary carotenoids, especially ⁇ -carotene, although not all of them possess this activity.
- Most carotenoids possess antioxidant, immuno-enhancement, antimutagenic, and anticarcinogenic functions. Because of the antioxidant property of carotenoids, the possibility exists that these compounds reduce lipid peroxidation, oxidative stress and free radical damage. Accordingly, they may protect against coronary heart disease, cancer and cataracts.
- Carotenoids are responsible for many of the red, orange and yellow colours of edible fruits and vegetables, for example, carrots, tomatoes and corn. They are also found in green leafy vegetables such as spinach.
- Nitrogen and sulphur containing compounds such as the glucosinolates found in the members of the Brassica genus (broccoli, cabbage, mustard), have received much attention recently. They are nitrogen and sulphur containing glycosides which in damaged tissues come into contact with the myrosinase enzyme and are hydrolysed, releasing the aglycone.
- lsothiocyanates and organosulphides are found in mustard oils and are widely distributed in plants. They have a variety of pharmacological and toxic activities, including goitrogenic, antibacterial, antifungal and antiprotozoal actions. Several substances in this group could block the toxic and neoplastic effects of a wide variety of chemical carcinogens.
- Plants of the Allium genus are also rich in sulphur containing compounds, such as S-methyl cysteine sulphoxide and S-allyl cysteine sulphoxide.
- sulphur containing compounds such as S-methyl cysteine sulphoxide and S-allyl cysteine sulphoxide.
- onions, garlic and compounds derived from them can exhibit health-promoting effects, for example, garlic is known for its health- promoting effects in relation to cardiovascular disease and some forms of cancer.
- terpenoid group other than carotenoids
- limonenes which have the fragrance of oranges and lemons
- glycyrrhizic acid found in liquorice root
- sterols sitosterol and stigmasterol
- Coenzyme Q or ubiquinones which are found in all organisms and function as electron carriers for the electron transport chain in mitochondria, are also terpenoids with C40-C50 side chains.
- flavonoids have been shown in vitro and in vivo to possess antimutagenic and anticarcinogenic properties, dietary flavonoid intake was not an important determinant of cancer mortality. No associations were found between flavonol and flavone intake and total and site-specific cancer mortality in the Zutphen Elderly Study. Similar results were also observed in the Seven countries Study, where the intake of flavanols and flavones ranged from 3 mg/day in a Finnish cohort to 70 mg/day in a Japanese cohort.
- a nutraceutical composition including one or more extracts of one or more plant components, the one or more extracts providing a combination of phytonutrient materials, the type and amount of which are in excess of a minimum value predetermined to provide a therapeutically or prophylactically desirable effect.
- administration of the nutraceutical composition according to this aspect of the present invention, orally or topically may function to treat a disease or a degenerative effect.
- administration of the nutraceutical composition according to this aspect of the present invention, orally or topically may improve skin health, reduce signs of skin ageing and/or reduce other forms of skin deterioration.
- long-term supplementation for 12 weeks with 24 mg/d of a carotenoid mix supplying similar amounts of beta-carotene, lutein and lycopene ameliorates redness of human skin induced by UV light.
- nutraceutical composition may optionally include a nutraceutically acceptable carrier.
- nutraceutical refers to any food or food ingredient (or additive) considered to provide medical or health benefits, including the prevention or treatment of disease.
- Food and food substances may qualify for health claims only if they meet FDA requirements, which require that the claims be supported by sufficient scientific evidence. However, nutraceuticals are not regulated as strictly as drugs.
- extract refers to any subset of a plant or plant product and may include, but is not limited to juice, pulp, infusion, cutting, distillate, distillation residue, pressing, nectar, pomace (crushing residue), etc.
- plant component may include, but is not limited to, any one or more of the following: leaf, stem, root, fruit, seed, nut, tuber, bulb, flower or branch, and the like, whether used in a fresh form or a dried form.
- a plant may be selected from the group consisting of, but not limited to one or more of olive trees, palm trees, fruit trees, plants used to make tea, other plants from which fruit and vegetables are derived, etc.
- the "minimum value” is indicated by way of a numeric “score” which gives an indication of the phytonutrient nutritional quality of the nutraceutical composition (or other composition depending on the aspect of the invention).
- the minimum value is predetermined based on, for example, the Reference Intakes (Rl) of the various phytonutrients present in the composition.
- Rl is a nutrient-based reference value for use in, inter alia, planning and assessing diets.
- the nutrient-based values are based on the lowest continuing intake level of a nutrient that, for a specified indicator of adequacy, will maintain a defined level of nutriture in an individual.
- the Rl is the amount of a phytonutrient per 100 kcal that a person should consume to ensure adequate intake of the phytonutrient for health purposes.
- a score may be calculated using any suitable scoring system.
- the following is a description of one suitable scoring system. However, modifications to this system may be implemented to improve the described system or simply generate a new system.
- the scoring system being described has five components of varying significance which are based on the content, variety and intactness of the phytonutrients in a nutraceutical composition.
- the described scoring system has an overall range of 0 to 100.
- Components 1 to 3 of the described scoring system are each scored in the range of 0 to 25 and the score given is based on the amount of the three major groups of phytonutrients present in a composition - (1) flavonoids, (2) carotenoids and (3) miscellaneous (other phytonutrients, including nitrogen or sulphur containing compounds).
- the phytonutrients have been classified on the basis of their structures.
- Table 2 lists the phytonutrient groups (numbered in accordance with their component number) and the sub-groups and individual compounds making up the sub-groups, as well as the major sources of these phytonutrients.
- Component 4 is scored in the range of 0 to 15 and is based on the amount of variety of phytonutrients in a nutraceutical composition.
- Component 5 is scored in the range of 0 to 10 and is a measure of the degree to which fresh plant components are altered, either physically, chemically or both from their natural state for incorporation into the extract and/or the nutraceutical composition.
- the described scoring system is summarised in Table 3.
- the score for components 1 to 3 is determined by the phytonutrient content of the composition expressed as the phytonutrient density (amount of phytonutrient in ⁇ g (or mg) per 1000 kJ energy (or per 100 kcal) derived from that particular composition).
- Each phytonutrient group is scored by comparing the phytonutrient density of the composition to the Reference Intakes (Rl) for that phytonutrient.
- a score is assigned by first calculating the phytonutrient density percentage of the Rl for each phytonutrient in the group. Second, a score from 0 to 25 is proportionately assigned based upon the percentage of the Rl of phytonutrients in each group, with 25 being the highest score for each phytonutrient group when one serving size of the nutraceutical composition provides 100% of the Rl of the phytonutrients of that group.
- the Rl of a phytonutrient may be based on reports from various cohort studies, where a large number of participants are followed up for long periods of time in order to observe disease incidence.
- Evidence may be gathered from research in which the associations of phytonutrient intake or consumption of phytonutrient rich foods and disease outcome are examined.
- the disease outcome may include risk of all-cause mortality, risk of cancer, heart disease and other diseases, and association with risk factors for disease.
- the Rl may also be determined from daily phytonutrient intakes of populations or sub- populations with longevity or with reduced risk of chronic diseases.
- Zutphen Elderly Study Korean eIi et al., Arch Intern Med 1996; 156: 637-42; Hertog et al., Lancet 1997; 349: 699
- the daily reference intake for the flavonol sub-group would be set as 20 mg/day.
- the Rl for the flavonol sub-group would be 1 mg/100 kcal based on a 2000 kcal per day diet.
- the Rl may be assigned to the phytonutrient group.
- the Rl for the phytonutrient group may be derived from the Rl for the major sub-group of the phytonutrient group or from the total Rl for all sub-groups.
- the scoring system counts the number of phytonutrient sub-groups that contribute substantially to meeting the three phytonutrient group requirements. A substantial contribution could be, for example, when the percentage of Rl for each phytonutrient of the sub-group is summed, a total percentage of greater than 5% for the phytonutrient sub-group.
- Phytonutrient groups and subgroups are outlined in Table 1. Phytonutrients (and their derivatives) that fall in the same sub-group are counted only once. For each of the phytonutrient groups, a threshold number is set and a maximum score is given even though the number of different phytonutrients exceeds the threshold number. In the described scoring system the threshold numbers for flavonoids is 7, for carotenoids is 3 and for the miscellaneous group, the threshold number is 5. Therefore, the variety score has a range from 0 to 15.
- Component 5 (the assessment of the intactness of phytonutrients) of the scoring system counts the number of food processing procedures that a nutraceutical composition undergoes (Table 4). The more food processing the composition undergoes, the more the integrity of the phytonutrients is diminished. Thus, the higher number of food processes undergone by the food item, the lower the score will be for component 5.
- the therapeutically or prophylactically desirable effect may relate to any disease or condition known to the person skilled in the art.
- diseases or conditions may include, but are not limited to, skin ageing, skin health, skin deterioration, skin conditions, cancer, cardiovascular disease, Alzheimer's disease, bone and joint diseases including osteoporosis and arthritis, obstructive airways diseases including asthma, allergic conditions, conditions affecting the gastrointestinal tract, autoimmune diseases, and diabetes.
- scoring system described above may also be applied to plant or plant components and even to animal-derived food products that may contain phytonutrients acquired when plant food is consumed by the animal.
- the nutraceutical composition includes an effective amount of phytonutrient materials selected from the group consisting of flavonols, flavones, flavanols, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosinolates, allium organosulphur compounds, phytosterols, monoterpenes, hydroxycinnamates, phenolic acids, stilbenes, choline derivatives, or a combination thereof.
- phytonutrient materials selected from the group consisting of flavonols, flavones, flavanols, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosin
- a nutraceutical composition of an embodiment of the present invention may include a combination of phytonutrient materials such that the minimum value is about 25.
- the value may be about 40, more preferably about 60.
- the nutraceutical composition according to this aspect of the present invention may further include one or more secondary nutraceutical components active nutritionally and/or therapeutically.
- the secondary nutraceutical component may be selected from one or more of vitamins, minerals, saccharides and/or other carbohydrates, fats, other nutritional supplements, hormones, and pharmaceuticals.
- the secondary nutraceutical component when present, may comprise from approximately 0.05% to 50% by weight, preferably approximately 1% to 40% by weight, more preferably 5% to 25% by weight, based on the total weight of the pharmaceutical composition.
- the nutraceutical composition according to this aspect of the present invention may further include a pharmaceutically acceptable carrier or excipient.
- the nutraceutical composition may be formulated for administration utilising a suitable route.
- the nutraceutical composition may be formulated for oral, topical, intravenous, intramuscular, intrarectal, transdermal, sublingual, subcutaneous or intranasal administration. An oral or topical route is preferred.
- the nutraceutical composition may be formulated as a food ingredient, food additive, tablet, capsule including soft gelatine capsules, caplet, lozenge, liquid including syrup, oil and suspension, powder, granules, chewing gum or the like.
- the nutraceutical composition may be formulated as a liquid, oil, paste, solution, dispersion, emulsion, lotion, gel, varnish or cream.
- the nutraceutical composition according to this aspect of the present invention may include a source of monounsaturated fatty acids or a derivative thereof.
- the source of the monounsaturated fatty acid is an edible oil. More preferably the edible oil is olive oil or red palm oil, or an extract thereof, or a mixture thereof.
- the source of monounsaturated fatty acids is present in an amount of from approximately 1 mg to 25 g, preferably 50 mg to 10 g, more preferably 100 mg to 5 g.
- the amount of monounsaturated fatty acids present in the nutraceutical composition amounts to a preferred daily intake of the monounsaturated fatty acids.
- the nutraceutical composition includes an extract from one or more of leafy green vegetables, garlic, onion, leeks, apple, pear, dried fruits or other food sources of the required phytonutrients, or a mixture thereof, with a source of monounsaturated fatty acids.
- the source of the monounsaturated fatty acid is an edible oil.
- the edible oil is olive oil or red palm oil, an extract thereof, or a mixture thereof.
- nutraceutical composition may optionally include a nutraceutically acceptable carrier.
- the extracts of the plant components are present in an amount of approximately 1 % to 99% by weight, preferably approximately 5% to 75% by weight, preferably approximately 10 to 50% by weight, based on the total weight of the composition.
- a cosmetic composition including one or more extracts of one or more plant components, the extracts providing a combination of phytonutrient materials, the type and amount of which are in excess of a minimum value predetermined to provide a therapeutically or prophylactically desirable effect.
- the cosmetic composition includes an effective amount of phytonutrient materials selected from the group consisting of flavonols, flavones, flavanols, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosinolates, allium organosulphur compounds, phytosterols, monoterpenes, hydroxycinnamates, phenolic acids, stilbenes, choline derivatives, or a combination thereof.
- phytonutrient materials selected from the group consisting of flavonols, flavones, flavanols, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosinolates
- the minimum value will generally be determined depending on the type of nutraceutical composition being considered.
- the cosmetic composition according to a preferred aspect of the present invention may include a combination of phytonutrient materials such that the minimum value is about 25.
- the value may be about 40, more preferably about 60.
- the cosmetic composition according to this aspect of the present invention may include a source of monounsaturated fatty acids or a derivative thereof.
- the source of the monounsaturated fatty acid is an edible oil.
- the edible oil is olive oil or red palm oil, or an extract thereof, or a mixture thereof.
- the source of monounsaturated fatty acids is present in an amount of from approximately 1 mg to 25 g, preferably 50 mg to 10 g, more preferably 100 mg to 5 g.
- the amount of monounsaturated fatty acids present in the cosmetic composition amounts to a preferred daily intake of the monounsaturated fatty acids.
- a cosmetic composition including an extract from one or more of leafy green vegetables, garlic, onion, leeks, apple, pear, dried fruits or other food sources of the required phytonutrients, or a mixture thereof, with a source of monounsaturated fatty acids.
- the source of the monounsaturated fatty acid is an edible oil.
- the edible oil is olive oil or red palm oil, an extract thereof, or a mixture thereof.
- the cosmetic composition of this aspect of the invention may further include a pharmaceutically acceptable carrier or excipient.
- the extracts of the plant components are present in an amount of approximately 1 to 99% by weight, preferably approximately 5% to 75% by weight, preferably approximately 10 to 50% by weight, based on the total weight of the composition.
- the cosmetic composition may be formulated for administration utilising a suitable route.
- the cosmetic composition may be formulated for oral, topical, intravenous, intramuscular, intrarectal, transdermal, subcutaneous, sublingual or intranasal administration.
- An oral or topical route is preferred.
- the nutraceutical composition may be formulated as a food ingredient, food additive, tablet, capsule including soft gelatine capsules, caplet, lozenge, liquid including syrup and oil, suspension, powder, granules, chewing gum or the like.
- the nutraceutical composition may be formulated as a liquid, oil, paste, solution, dispersion, emulsion, lotion, gel, varnish or cream.
- the cosmetic composition may also further include one or more cosmetic additives.
- the cosmetic additives may be selected from the group consisting of water-soluble or liposoluble dyes, fillers, lipophilic or hydrophilic active agents, fragrances, additional carriers or excipients, lubricants, buffers, antibacterials, bulking agents, plasticisers, binding agents, antioxidants and stabilising agents.
- Suitable fillers or excipients may be selected from the group consisting of talc, titanium dioxide, starch, cornstarch, modified cornstarch, kaolin, cellulose (microcrystalline or powdered) and mixtures thereof.
- Suitable binding agents include polyvinyl pyrrolidine, hydroxypropyl cellulose and hydroxypropyl methyl cellulose.
- Suitable solution vehicles include, but are not limited to, ethanol, water, propylene glycol, butylene glycol, acetone, or pharmaceutically acceptable vehicles.
- the cosmetic composition may further include an active agent selected from the group consisting of hydrating agents, UV screening agents, depigmenting agents, bleaching agents and tensioning agents.
- Suitable lotion bases include, but are not limited to, hydrophilic ointment or petrolatum.
- Suitable gelling agents include, but are not limited to, xanthan gum, gellan gum, carboxymethylcellulose, polyquaternium-10, methyl cellulose, ethyl cellulose, hydroxyethylcellulose, hydroxypropylcellulose, chitosan, hydroxypropylmethylcellulose, agar-agar, carrageenans, alginates, carob gum, guar gum, gum Arabic, karaya gum, gum tragacanth, ghatti gum, pectins, gelatin, caseinates, hydroxypropyl guar, ammoniated glycyrrhizinate and carbomer.
- a modified food composition including a nutraceutical composition, as discussed above.
- the modified food composition may be characterised by exhibiting a numerical value of phytonutrient quality above a predetermined reference value.
- the predetermined reference value may equate to a maximum numerical value for an unmodified food composition.
- the modified food composition may include any of the following:
- dairy products including milk, ice-cream, yoghurt, cheese etc
- grain based products including rice based products such as rice cakes, corn based products such as pop corn etc
- products derived at least in part from fruit including tarts, pies, muesli bars, juices, cordials, tinned fruit, snack foods
- the food composition includes an effective amount of phytonutrient materials selected from the group consisting of flavonols, flavones, flavanols, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosinolates, allium organosulphur compounds, phytosterols, monoterpenes, hydroxycinnamates, phenolic acids, stilbenes, choline derivatives, or a combination thereof.
- phytonutrient materials selected from the group consisting of flavonols, flavones, flavanols, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosinolates
- the minimum value will generally be determined depending on the type of nutraceutical composition being considered.
- the food composition according to a preferred aspect of the present invention may include a combination of phytonutrient materials such that the minimum value is about 25.
- the value may be about 40, more preferably about 60.
- the food composition according to this aspect of the present invention may further include one or more secondary nutraceutical components active nutritionally and/or therapeutically.
- the secondary nutraceutical component may be selected from one or more of vitamins, minerals, saccharides and/or other carbohydrates, fats, other nutritional supplements, hormones, and pharmaceuticals.
- the secondary nutraceutical component when present, may comprise from approximately 0.05% to 50% by weight, preferably approximately 1% to 40% by weight, more preferably 5% to 25% by weight, based on the total weight of the pharmaceutical composition.
- composition according to this aspect of the present invention may include a source of monounsaturated fatty acids or a derivative thereof.
- the source of monounsaturated fatty acids is present in an amount of from approximately 1 mg to 25 g, preferably 50 mg to 10 g, more preferably 100 mg to 5 g.
- the amount of monounsaturated fatty acids present in the food composition amounts to a preferred daily intake of the monounsaturated fatty acids.
- the source of monounsaturated fatty acid is an edible oil. More preferably, the edible oil is olive oil, red palm oil or an extract thereof, or a mixture thereof.
- the composition includes an extract from one or more of leafy green vegetables, garlic, onion, leeks, apple, pear, dried fruits or other food sources of the required phytonutrients, or a mixture thereof, with a source of monounsaturated fatty acids.
- the extracts of the plant components are present in an amount of approximately 1 to 99% by weight, preferably approximately 5% to 75% by weight, more preferably approximately 10 to 50% by weight, based on the total weight of the composition.
- the composition is used to prophylactically or therapeutically treat skin ageing, skin health, skin deterioration, skin conditions, cancer, cardiovascular disease, Alzheimer's disease, bone and joint diseases including osteoporosis and arthritis, obstructive airways diseases including asthma, allergic conditions, conditions affecting the gastrointestinal tract, autoimmune diseases, and diabetes.
- the composition is selected from the group consisting of a nutraceutical composition and a cosmetic composition as described above.
- a method of prophylactically or therapeutically treating a disease or degenerative effect which method includes administering to a human a composition including one or more extracts of one or more plant components, the extracts providing a combination of phytonutrient materials, the type and amount of which are in excess of a minimum value predetermined to provide a therapeutically or prophylactically desirable effect.
- a method of determining the nutritional value of a nutraceutical composition and applying a phytonutrient nutritional score thereto which method includes:
- the present invention provides a method of determining the nutritional value of a food composition and applying a phytonutrient nutritional score thereto. Accordingly, the method includes:
- the food composition may be of any suitable type as described above.
- the food substance may include a dietary supplement.
- the food substance is preferably a flour- based substance, a substance containing and/or consisting of fruit and/or vegetables, a rice-based substance or a dairy-based substance.
- the phytonutrient content, phytonutrient variety and phytonutrient integrity may be determined as described above.
- the predetermined value ranges are the Reference Intakes described above. More preferably, the predetermined value ranges are determined at regular intervals based on the information available regarding optimal phytonutrient intake at the time.
- the phytonutrient nutritional score may be determined as described above.
- phytonutrient nutritional scores are given in the range of 0 to 100.
- the predetermined value ranges may be compiled in order to create an index of the predetermined value ranges.
- the phytonutrient nutritional scores which have been determined may be independently compiled in order to create an index of the phytonutrient nutritional scores.
- the invention provides a method of controlling the nutritional value of a nutraceutical composition and/or a cosmetic composition and/or a food composition consumed by an individual. Accordingly, the method includes:
- the method is used to increase the phytonutrient nutritional score of the food substance.
- the invention provides a computer useable medium for determining the nutritional value of nutraceutical composition and/or a cosmetic composition and/or a food composition. Accordingly, such medium includes:
- (c) means for summing the correlated nutritional components to derive a phytonutrient nutritional score indicative of the nutritional value of the food substance
- the computer useable medium may be stored in any suitable manner known per se in the prior art.
- the medium may be selected from a compact disk, digital video disk, hard drive or floppy disk.
- the computer useable medium is arranged to provide, as an output, a phytonutrient nutritional score and/or a list of any phytonutrient nutritional scores determined by the method described above so as to form an index of phytonutrient nutritional scores.
- Reference Intakes were calculated based on the data published in the cited references. Generally, data from reports of daily intakes of sub-groups of phytonutrients in populations or sub-populations with longevity or reduced risk of chronic disease were compared and a representative daily intake was calculated for each sub-group of phytonutrients. The Reference Intake, measured in mg/100kcal was calculated from the representative daily intake based on a 2000 kcal per day diet. Table 5 - Reference Intakes
- the component 1 to 3 scores were proportionately assigned based on the percentage Rl of the sub-group having the highest percentage Rl.
- the score for the carotenoid group was calculated based on the percentage Rl of the hydroxy carotene sub-group alone, 19 being 77% of the possible total of 25.
- the variety score (component 4) was determined by summing the number of phytonutrient sub-groups having a value of greater than 5% of the Rl for that phytonutrient sub-group.
- the integrity score (component 5) is the maximum score available.
- the percentage Rl of the flavanols, 4% indicated that the flavanols did not contribute substantially to meeting the flavonoid group (component 1) requirement. Accordingly, the flavanol sub-group was not counted in the determination of the variety score.
- the integrity score assigned to the salad vegetables was the maximum score available as the salad vegetables had not undergone any processing steps which diminished the phytonutrient integrity of the salad vegetables.
- the integrity score assigned to the ready-to-eat soup was the maximum score available as no processing steps which diminished the phytonutrient integrity of the vegetables had been undergone by the food.
- flavoured (dairy and soy) drink having the following approximate proportions of ingredients:
- Table 12 Phytonutrient analysis of 100g of flavoured (dairy and soy) drink
- the integrity score assigned to the milk drink was the minimum score available due to the high number of processing steps the product was subjected to which diminished the phytonutrient integrity of the drink.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Toxicology (AREA)
- Polymers & Plastics (AREA)
- Neurology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Obesity (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2005306575A AU2005306575A1 (en) | 2004-11-16 | 2005-11-16 | Improved nutraceutical composition |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2004906558A AU2004906558A0 (en) | 2004-11-16 | Nutraceutical composition (3) | |
AU2004906558 | 2004-11-16 | ||
AU2005900508 | 2005-02-04 | ||
AU2005900508A AU2005900508A0 (en) | 2005-02-04 | Improved nutraceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006053379A1 true WO2006053379A1 (en) | 2006-05-26 |
Family
ID=36406764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/AU2005/001741 WO2006053379A1 (en) | 2004-11-16 | 2005-11-16 | Improved nutraceutical composition |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006053379A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008080037A2 (en) * | 2006-12-21 | 2008-07-03 | Isp Investments Inc. | Carotenoids of enhanced bioavailability |
US9937220B2 (en) | 2009-03-24 | 2018-04-10 | Universiti Putra Malaysia | Anti-diabetic nutraceutical composition from palm leaf extract |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0954984A1 (en) * | 1998-05-04 | 1999-11-10 | Källna Specialprodukter AB | Dietary fibre composition |
EP1026164A1 (en) * | 1999-02-02 | 2000-08-09 | ADM Cocoa B.V. | Process for extracting polyphenolic antioxidants from purine-containing plants |
WO2000064282A1 (en) * | 1999-04-27 | 2000-11-02 | Diomede Antonio Tortora | Nutraceuticals and ingredients for functional foods |
WO2003017784A1 (en) * | 2001-08-30 | 2003-03-06 | Council Of Scientific And Industrial Research | Herbal nutraceutical formulation for females/expectant mothers and its process of preparation |
WO2003055324A1 (en) * | 2001-12-21 | 2003-07-10 | Raisio Benecol Oy | Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis |
US20030185911A1 (en) * | 2002-03-25 | 2003-10-02 | Qazi Gulam Nabi | Herbal nutraceuticals and a process for preparing the same |
WO2004023889A2 (en) * | 2002-09-12 | 2004-03-25 | Armadillo Pharmaceuticals | Full range nutritional supplements from plant materials and methods for their manufacture |
US20040071752A1 (en) * | 1999-11-06 | 2004-04-15 | Janmarie Hornack | Dietary supplement containing alkaline electrolyte buffers |
-
2005
- 2005-11-16 WO PCT/AU2005/001741 patent/WO2006053379A1/en active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0954984A1 (en) * | 1998-05-04 | 1999-11-10 | Källna Specialprodukter AB | Dietary fibre composition |
EP1026164A1 (en) * | 1999-02-02 | 2000-08-09 | ADM Cocoa B.V. | Process for extracting polyphenolic antioxidants from purine-containing plants |
WO2000064282A1 (en) * | 1999-04-27 | 2000-11-02 | Diomede Antonio Tortora | Nutraceuticals and ingredients for functional foods |
US20040071752A1 (en) * | 1999-11-06 | 2004-04-15 | Janmarie Hornack | Dietary supplement containing alkaline electrolyte buffers |
WO2003017784A1 (en) * | 2001-08-30 | 2003-03-06 | Council Of Scientific And Industrial Research | Herbal nutraceutical formulation for females/expectant mothers and its process of preparation |
WO2003055324A1 (en) * | 2001-12-21 | 2003-07-10 | Raisio Benecol Oy | Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis |
US20030185911A1 (en) * | 2002-03-25 | 2003-10-02 | Qazi Gulam Nabi | Herbal nutraceuticals and a process for preparing the same |
WO2004023889A2 (en) * | 2002-09-12 | 2004-03-25 | Armadillo Pharmaceuticals | Full range nutritional supplements from plant materials and methods for their manufacture |
Non-Patent Citations (4)
Title |
---|
BAMBA T. ET AL: "A new prebiotic from germinated barley for nutraceutical treatment of ulcerative colitis", JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 17, 2002, pages 818 - 824 * |
JARIWALLA R.J.: "Rice-bran products: phytonutrients with potential applications in preventive and clinical medicine", DRUGS EXPTL. CLIN. RES, vol. XXVII, no. 1, 2001, pages 17 - 26 * |
OH S.-H. ET AL: "Germinated Brown Rice Extract Shows a Nutraceutical Effect in the Recovery of Chronic Alcohol-Related Symptoms", JOURNAL OF MEDICINAL FOOD, vol. 6, no. 2, 2003, pages 115 - 121 * |
WATTANAPENPAIBOON N. ET AL: "Phytonutrient deficiency: the place of palm fruit", ASIA PACIFIC J CLIN NUTR, vol. 12, no. 3, 2003, pages 363 - 368 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008080037A2 (en) * | 2006-12-21 | 2008-07-03 | Isp Investments Inc. | Carotenoids of enhanced bioavailability |
WO2008080037A3 (en) * | 2006-12-21 | 2008-11-27 | Isp Investments Inc | Carotenoids of enhanced bioavailability |
US8613946B2 (en) | 2006-12-21 | 2013-12-24 | Isp Investment Inc. | Carotenoids of enhanced bioavailability |
US9937220B2 (en) | 2009-03-24 | 2018-04-10 | Universiti Putra Malaysia | Anti-diabetic nutraceutical composition from palm leaf extract |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Drabińska et al. | Broccoli by-products improve the nutraceutical potential of gluten-free mini sponge cakes | |
Gupta et al. | Functional food with some health benefits, so called superfood: A review | |
Sidhu et al. | Bioactive compounds in banana fruits and their health benefits | |
Yahia et al. | The contribution of fruit and vegetable consumption to human health | |
Singh et al. | Bioactive compounds in banana and their associated health benefits–A review | |
Swami et al. | Jackfruit and its many functional components as related to human health: a review | |
Hui et al. | Handbook of vegetable preservation and processing | |
Dixit et al. | Functional foods: Exploring the health benefits of bioactive compounds from plant and animal sources | |
Liu | Potential synergy of phytochemicals in cancer prevention: mechanism of action | |
Das et al. | Black rice: A comprehensive review on its bioactive compounds, potential health benefits and food applications | |
Denny et al. | Plant foods and health: focus on plant bioactives | |
Pérez-Chabela et al. | Agroindustrial coproducts as sources of novel functional ingredients | |
Sawicka et al. | Nutraceuticals in food and pharmacy. A Review | |
Fardet | New concepts and paradigms for the protective effects of plant-based food components in relation to food complexity | |
Shajan et al. | Comprehensive comparative insights on physico-chemical characteristics, bioactive components, and therapeutic potential of pumpkin fruit | |
Sharma et al. | Bioavailability of nutrients and safety measurements | |
Anandhi et al. | Extraction and food enrichment applications of black carrot phytocompounds: A review | |
Alu'datt et al. | Date palm (Phoenix dactylifera) bioactive constituents and their applications as natural multifunctional ingredients in health‐promoting foods and nutraceuticals: A comprehensive review | |
Kalia et al. | Nutritional enhancement of vegetable crops (with major emphasis on Broccoli: a new cole crop in India) | |
Turturică et al. | Carrot–Application in food industry and health benefits–review | |
Rajput et al. | Pistachio | |
Lindsay | The nutritional enhancement of plant foods in Europe ‘NEODIET’ | |
Singh | Bioactive nutrients in vegetables for human nutrition and health | |
Wahlqvist et al. | Phytonutrients as Bioactive Food Components | |
WO2006053379A1 (en) | Improved nutraceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005306575 Country of ref document: AU Ref document number: 555199 Country of ref document: NZ |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2005306575 Country of ref document: AU Date of ref document: 20051116 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005306575 Country of ref document: AU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 05803023 Country of ref document: EP Kind code of ref document: A1 |